By: Marie Huang
–
| G | A | L | K | N | Y | L | O | M | O | R | C |
| B | U | A | O | E | B | R | C | A | T | H | E |
| O | R | A | Z | R | T | L | H | N | R | Y | T |
| S | N | A | I | E | A | O | I | P | S | L | I |
| E | R | E | E | F | L | T | T | N | O | T | R |
| N | L | O | A | T | E | A | A | I | F | I | I |
| T | K | L | O | R | O | N | S | D | F | L | Z |
| A | U | L | E | I | I | T | E | T | I | E | I |
| N | A | O | I | S | E | U | E | S | I | N | N |
| I | O | L | O | P | A | T | A | D | I | N | E |
| T | H | E | O | P | H | Y | L | L | I | N | E |
| L | I | F | A | N | E | D | L | I | S | P | I |
FIND THE FOLLOWING WORDS:
AZELASTINE
THEOPHYLLINE
SILDENAFIL
LORATADINE
GUAIFENESIN
CETIRIZINE
CROMOLYN
KETOTIFEN
OLOPATADINE
BOSENTAN
NOTICE A THEME?
By: Zurriya Faran, PharmD Candidate c/o 2031 The visible loss of skin pigmentation often indicates…
By: Archana Murugan, PharmD candidate c/o 2029 Overview Thiamine metabolic dysfunction syndrome (TMDS) refers…
By: Kevin Lee, PharmD Candidate c/o 2028, Angela Yin, PharmD Candidate c/o 2028 The…
By: Aymon Choudhury, PharmD Candidate c/o 2027 APPE questions: How did your APPE rotations shape…
By: Sariah Grant, PharmD Candidate c/o 2027 The rise of glucagon-like peptide -1 receptor…
By: Amanda Kastel, PharmD Candidate c/o 2027 In February 2026, FDA Commissioner Marty Makary stated…